How do the cardiac valves open and close during the cardiac cycle?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cardiac Valve Opening and Closing Mechanism

Heart valves open and close primarily through inertial flow forces rather than simple pressure gradients, with valve leaflet motion being a dynamic, continuous process throughout the cardiac cycle—not occurring during discrete "isovolumic" periods as traditionally taught.

Fundamental Mechanism

The traditional Wiggers Diagram concept of valve function based solely on pressure differences has been challenged by recent evidence. Valves open and close in response to inertial flow through the valves themselves, not just instantaneous pressure transmission through incompressible blood 1. This represents a paradigm shift from the century-old teaching that pressure gradients alone control valve motion.

Key Findings on Valve Timing

Recent in vivo data demonstrates that:

  • No consistent isovolumic periods exist during the cardiac cycle
  • The mitral valve closes at variable points during the rising phase of left ventricular pressure (not at a fixed pressure crossover point)
  • Aortic valve closure and mitral valve opening occur simultaneously at the end of systolic pressure drop 1

Structural Basis of Valve Function

Aortic Valve Anatomy

The aortic valve consists of three semi-lunar leaflets attached to a crown-like 3D structure (not a simple ring). The cusps are:

  • Mobile and free at the commissures
  • Symmetrical in normal valves
  • Attached to a fibrous sleeve that connects to the aorta above and left ventricular outflow tract below
  • Dynamically changing in size throughout the cardiac cycle in response to inner pressure 2

Mitral Valve Dynamics

The mitral valve demonstrates complex dimensional changes:

  • Maximal opening occurs in late diastole, with the annular diameter reaching 29.3 ± 3.5 mm and area of 962.8 ± 149.3 mm²
  • Maximal valve opening angles (anterior: 68.3° ± 5.6°, posterior: 55.9° ± 5.4°) also occur in late diastole
  • Minimal opening occurs in mid-systole, with annular diameter of 9.8 ± 1.7 mm and area of 76.2 ± 27.3 mm² 3

Role of Papillary Muscles

The papillary muscles play an active role in valve function beyond simple tethering:

  • Papillary muscle shortening throughout isovolumic relaxation suggests active participation in opening the mitral valve
  • Maximal papillary muscle elongation occurs 25 ± 2 ms after onset of ejection
  • Papillary muscle shortens by 14 ± 4% during the cycle
  • 39 ± 7% of papillary muscle shortening occurs after the aortic incisura, indicating continued active function during early diastole
  • Elongation in late diastole is necessary to permit proper leaflet closure 4

Clinical Classification of Valve Motion

When assessing valve dysfunction, leaflet motion is classified using Carpentier's system 2:

  • Type I: Normal leaflet motion (regurgitation due to annular dilatation or leaflet perforation)
  • Type II: Excessive motion (prolapse)
  • Type III: Restrictive motion (limited opening or closing)

Important Clinical Caveats

Prosthetic Valve Assessment

For mechanical valves, fluoroscopy or cine-CT is essential to assess leaflet motion because echocardiographic imaging is obscured by strong reflections from the mechanical components. Opening and closing angles must be measured from side views and compared to expected values for that valve type 5.

Bioprosthetic Valve Considerations

Bioprosthetic valve stenosis may result from:

  • Structural valve deterioration
  • Reversible valve thrombosis (thin thrombus layer responsive to oral anticoagulation)
  • Pannus formation
  • 3D TEE or 4D CT imaging is useful to distinguish thrombosis from other causes 5

Secondary Valve Dysfunction

In secondary tricuspid or mitral regurgitation, increased leaflet tethering (measured as tenting area >1.0 cm² or coaptation distance >0.76 cm) predicts severity and residual regurgitation after surgical repair 2.

Related Questions

Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
What is the appropriate evaluation and management for a patient with a 0.5 cm round ground‑glass opacity in the right upper lung who has been exposed to chemicals and now presents with a chronic cough?
How can a pneumoperitoneum lead to subcutaneous emphysema?
What is the indication for a soap containing 5% benzoyl peroxide?
In an adult patient who has been using Adderall (amphetamine/dextroamphetamine) 10 mg sporadically and is now establishing care, can I initiate a daily dose of 10 mg?
In a patient with heart failure and a pulmonary capillary wedge pressure of 24 mmHg, cardiac output of 4 L/min, and cardiac index of 1.8 L/min/m², should milrinone or dobutamine be used?
Should a patient receiving a GLP‑1 receptor agonist injection who develops depressive symptoms or suicidal ideation discontinue the medication, and what alternative glucose‑lowering therapies are recommended?
What is the recommended starting dose of Adderall XR (mixed amphetamine salts) for an adult with ADHD?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.